Carfilzomib as salvage therapy in Waldenstrom macroglobulinemia: a case series
Leuk Lymphoma
.
2018 Jan;59(1):259-261.
doi: 10.1080/10428194.2017.1321749.
Epub 2017 Jun 5.
Authors
David H Vesole
1
,
Joshua Richter
1
,
Noa Biran
1
,
Laura McBride
1
,
Palka Anand
1
,
Mei Huang
2
,
Anita-Zahlten Kumeli
2
,
Zandra Klippel
2
,
Karim Iskander
2
,
David S Siegel
1
Affiliations
1
a John Theurer Cancer Center, Hackensack University Medical Center , Hackensack , NJ , USA.
2
b Amgen Inc. , Thousand Oaks , CA , USA.
PMID:
28583038
DOI:
10.1080/10428194.2017.1321749
No abstract available
Publication types
Case Reports
Letter
MeSH terms
Aged
Female
Humans
Male
Middle Aged
Oligopeptides / therapeutic use*
Salvage Therapy / methods*
Treatment Outcome
Waldenstrom Macroglobulinemia / drug therapy*
Substances
Oligopeptides
carfilzomib